Stephen Kimmel

Stephen Kimmel,

Dean’s Professor And Chair

Department: Department of Epidemiology
Business Phone: (352) 273-5460
Business Email: skimmel@ufl.edu

About Stephen Kimmel

Stephen Kimmel, MD, MSCE, is a graduate of Princeton University and New York University School of Medicine. He completed his internal medicine training at Harvard’s Brigham and Women’s Hospital and his cardiology fellowship at the University of Pennsylvania. He has a Master of Science in epidemiology from the Perelman School of Medicine at the University of Pennsylvania. His research, which has been funded continuously for the past 26 years, focuses on improving the use of existing medical therapies, particularly related to genetic epidemiology, adherence, and patient-centered outcomes. His most recent work focuses on novel methods of prediction of outcomes among patients in order to improve patient selection for surgical procedures and lung transplantation. He has served as principal investigator on numerous federal grants, including five R01s, a K24, a large NHLBI N01, a PCORI grant, and a U01 grant. He teaches courses in epidemiology and has also been instrumental in the development and growth of several graduate programs in epidemiology.

Teaching Profile

Courses Taught
2021-2024
PHC7934 Seminar I: Epidemiology Past, Present, and Future
2021-2022,2024
PHC6971 Research for Master’s Thesis
2022-2023
PHC6941 MPH Applied Practice Experience
2022-2024
PHC6003 Epidemiology of Chronic Diseases and Disability
2022-2024
PHC7918 Independent Study
2022-2024
PHC7979 Advanced Research
2023
PHC6937 Special Topics in Public Health
2023-2024
PHC7980 Research for Doctoral Dissertation
2024
PHC7727 Grant Writing for Population Health Research

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0003-3673-2361

Areas of Interest
  • Cardiovascular Epidemiology
  • Pharmacoepidemiology
  • Prediction Modeling

Publications

2024
Confidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints.
Journal of the American Medical Informatics Association : JAMIA. 31(4):809-819 [DOI] 10.1093/jamia/ocad248. [PMID] 38065694.
2024
Predictors of left atrial appendage thrombus in atrial fibrillation patients undergoing cardioversion.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. [DOI] 10.1007/s10840-024-01868-x. [PMID] 38995603.
2024
Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis.
Frontiers in pharmacology. 15 [DOI] 10.3389/fphar.2024.1379251. [PMID] 38846094.
2024
Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries With Heart Failure.
JACC. Advances. 3(7) [DOI] 10.1016/j.jacadv.2024.100958. [PMID] 39129974.
2023
A Conceptual Model for Sources of Differential Selection in Lung Transplant Allocation.
Annals of the American Thoracic Society. 20(2):226-235 [DOI] 10.1513/AnnalsATS.202202-105OC. [PMID] 36044711.
2023
Cost-effectiveness of bivalirudin in pediatric ventricular assist devices.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 42(3):390-397 [DOI] 10.1016/j.healun.2022.10.006. [PMID] 36333207.
2023
Dynamic logistic state space prediction model for clinical decision making.
Biometrics. 79(1):73-85 [DOI] 10.1111/biom.13593. [PMID] 34697801.
2023
Dynamic prediction modeling of postoperative mortality among patients undergoing surgical aortic valve replacement in a statewide cohort over a 12-year period.
JTCVS open. 15:94-112 [DOI] 10.1016/j.xjon.2023.07.011. [PMID] 37808034.
2022
A Comparison of Methods to Detect Changes in Prediction Models.
Methods of information in medicine. 61(1-02):19-28 [DOI] 10.1055/s-0042-1742672. [PMID] 35151231.
2022
Are novel glucose-lowering agents’ cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment.
Diabetes, obesity & metabolism. 24(1):154-159 [DOI] 10.1111/dom.14540. [PMID] 34472689.
2022
Clinical impact of a modified lung allocation score that mitigates selection bias.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 41(11):1590-1600 [DOI] 10.1016/j.healun.2022.08.003. [PMID] 36064649.
2022
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials.
Diabetes care. 45(4):1007-1012 [DOI] 10.2337/dc21-1722. [PMID] 35349656.
2022
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population-Based Cohort Studies.
Clinical pharmacology and therapeutics. 111(1):227-242 [DOI] 10.1002/cpt.2381. [PMID] 34331322.
2022
Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach.
Frontiers in pharmacology. 13 [DOI] 10.3389/fphar.2022.834743. [PMID] 35359843.
2022
Modified Brier score for evaluating prediction accuracy for binary outcomes.
Statistical methods in medical research. 31(12):2287-2296 [DOI] 10.1177/09622802221122391. [PMID] 36031854.
2022
Outcomes of the National Heart, Lung, and Blood Institute K12 program in emergency care research: 7-year follow-up.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 29(10):1197-1204 [DOI] 10.1111/acem.14563. [PMID] 35848052.
2022
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.
Journal of managed care & specialty pharmacy. 28(12):1400-1409 [DOI] 10.18553/jmcp.2022.28.12.1400. [PMID] 36427343.
2021
Comparing medication adherence using a smartphone application and electronic monitoring among patients with acute coronary syndrome.
Applied nursing research : ANR. 60 [DOI] 10.1016/j.apnr.2021.151448. [PMID] 34247788.
2021
Comparison of dynamic updating strategies for clinical prediction models.
Diagnostic and prognostic research. 5(1) [DOI] 10.1186/s41512-021-00110-w. [PMID] 34865652.
2021
Mitigating selection bias in organ allocation models.
BMC medical research methodology. 21(1) [DOI] 10.1186/s12874-021-01379-7. [PMID] 34548017.
2021
Pharmacoepidemiology: A time for a new multidisciplinary approach to precision medicine.
Pharmacoepidemiology and drug safety. 30(8):985-992 [DOI] 10.1002/pds.5226. [PMID] 33715268.
2020
A behavioral economics-based telehealth intervention to improve aspirin adherence following hospitalization for acute coronary syndrome.
Pharmacoepidemiology and drug safety. 29(5):513-517 [DOI] 10.1002/pds.4988. [PMID] 32237005.
2020
A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus.
Seminars in arthritis and rheumatism. 50(4):527-533 [DOI] 10.1016/j.semarthrit.2020.03.019. [PMID] 32446021.
2020
Correction: Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group.
Genetics in medicine : official journal of the American College of Medical Genetics. 22(10) [DOI] 10.1038/s41436-020-0910-6. [PMID] 32719392.
2020
COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance.
Annals of internal medicine. 173(8):652-653 [DOI] 10.7326/M20-2959. [PMID] 32543881.
2020
Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.
Clinical pharmacology and therapeutics. 107(6):1420-1433 [DOI] 10.1002/cpt.1755. [PMID] 31869433.
2020
Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events.
Clinical pharmacology and therapeutics. 108(2):377-386 [DOI] 10.1002/cpt.1845. [PMID] 32275326.
2020
Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension.
Pulmonary circulation. 10(4) [DOI] 10.1177/2045894020966889. [PMID] 33282194.
2020
Testing small study effects in multivariate meta-analysis.
Biometrics. 76(4):1240-1250 [DOI] 10.1111/biom.13342. [PMID] 32720712.
2020
The Galaxy Plot: A New Visualization Tool for Bivariate Meta-Analysis Studies.
American journal of epidemiology. 189(8):861-869 [DOI] 10.1093/aje/kwz286. [PMID] 31942603.
2020
The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Cardiovascular diabetology. 19(1) [DOI] 10.1186/s12933-020-00999-5. [PMID] 32098624.
2020
Trends in Mechanical Support Use as a Bridge to Adult Heart Transplant Under New Allocation Rules.
JAMA cardiology. 5(6):728-729 [DOI] 10.1001/jamacardio.2020.0667. [PMID] 32293645.
2020
Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 39(7):725-726 [DOI] 10.1016/j.healun.2020.02.018. [PMID] 32307250.
2019
Predictive risk stratification using HEART (history, electrocardiogram, age, risk factors, and initial troponin) and TIMI (thrombolysis in myocardial infarction) scores in non-high risk chest pain patients: An African American urban community based hospital study.
Medicine. 98(32) [DOI] 10.1097/MD.0000000000016370. [PMID] 31393346.
2019
Qualitative study of system-level factors related to genomic implementation.
Genetics in medicine : official journal of the American College of Medical Genetics. 21(7):1534-1540 [DOI] 10.1038/s41436-018-0378-9. [PMID] 30467402.
2018
Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group.
Genetics in medicine : official journal of the American College of Medical Genetics. 20(6):655-663 [DOI] 10.1038/gim.2017.144. [PMID] 28914267.
2018
Heart Failure Home Management Challenges and Reasons for Readmission: a Qualitative Study to Understand the Patient’s Perspective.
Journal of general internal medicine. 33(10):1700-1707 [DOI] 10.1007/s11606-018-4542-3. [PMID] 29992429.
2018
Incorporating patient-centered factors into heart failure readmission risk prediction: A mixed-methods study.
American heart journal. 200:75-82 [DOI] 10.1016/j.ahj.2018.03.002. [PMID] 29898852.
2018
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
JACC. Cardiovascular interventions. 11(2):181-191 [DOI] 10.1016/j.jcin.2017.07.022. [PMID] 29102571.
2018
Palliative care: Is now the time?
European journal of cardiovascular nursing. 17(6):474-476 [DOI] 10.1177/1474515117751905. [PMID] 29292659.
2018
Recovering Quantum Gates from Few Average Gate Fidelities.
Physical review letters. 121(17) [DOI] 10.1103/PhysRevLett.121.170502. [PMID] 30411921.
2018
Sustained Posttransplantation Diabetes Is Associated With Long-Term Major Cardiovascular Events Following Liver Transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 18(1):207-215 [DOI] 10.1111/ajt.14401. [PMID] 28640504.
2018
The First National Institutes of Health Institutional Training Program in Emergency Care Research: Productivity and Outcomes.
Annals of emergency medicine. 72(6):679-690 [DOI] 10.1016/j.annemergmed.2018.06.018. [PMID] 30078658.
2017
Association Between Patient-Reported Medication Adherence and Anticoagulation Control.
The American journal of medicine. 130(9):1092-1098.e2 [DOI] 10.1016/j.amjmed.2017.03.038. [PMID] 28454906.
2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
Clinical pharmacology and therapeutics. 102(3):397-404 [DOI] 10.1002/cpt.668. [PMID] 28198005.
2017
Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.
International journal of cardiology. 228:761-770 [DOI] 10.1016/j.ijcard.2016.11.245. [PMID] 27888753.
2017
Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.
Pharmacogenomics. 18(11):1059-1073 [DOI] 10.2217/pgs-2017-0046. [PMID] 28686080.
2017
Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.
Journal of the American College of Cardiology. 70(15):1919-1930 [DOI] 10.1016/j.jacc.2017.08.036. [PMID] 28982506.
2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.
BMJ open diabetes research & care. 5(1) [DOI] 10.1136/bmjdrc-2017-000400. [PMID] 28878934.
2017
Thromboembolic and neurologic sequelae of discontinuation of an antihyperlipidemic drug during ongoing warfarin therapy.
Scientific reports. 7(1) [DOI] 10.1038/s41598-017-18318-6. [PMID] 29269848.
2016
A randomized trial of lottery-based incentives and reminders to improve warfarin adherence: the Warfarin Incentives (WIN2) Trial.
Pharmacoepidemiology and drug safety. 25(11):1219-1227 [DOI] 10.1002/pds.4094. [PMID] 27592594.
2016
A systematic analysis and comparison of warfarin initiation strategies.
Pharmacogenetics and genomics. 26(10):445-52 [DOI] 10.1097/FPC.0000000000000235. [PMID] 27383664.
2016
Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease.
Journal of the American Heart Association. 5(6) [DOI] 10.1161/JAHA.116.003339. [PMID] 27247339.
2016
Comparing Perspectives of Patients, Caregivers, and Clinicians on Heart Failure Management.
Journal of cardiac failure. 22(3):210-7 [DOI] 10.1016/j.cardfail.2015.10.011. [PMID] 26505810.
2016
EVALUATING RISK-PREDICTION MODELS USING DATA FROM ELECTRONIC HEALTH RECORDS.
The annals of applied statistics. 10(1):286-304 [PMID] 27158296.
2016
Predicting prolonged dose titration in patients starting warfarin.
Pharmacoepidemiology and drug safety. 25(11):1228-1235 [DOI] 10.1002/pds.4069. [PMID] 27456080.
2016
The IGNITE network: a model for genomic medicine implementation and research.
BMC medical genomics. 9 [DOI] 10.1186/s12920-015-0162-5. [PMID] 26729011.
2016
The prediction accuracy of dynamic mixed-effects models in clustered data.
BioData mining. 9 [DOI] 10.1186/s13040-016-0084-6. [PMID] 26819631.
2016
Warfarin Dosing Algorithms and the Need for Human Intervention.
The American journal of medicine. 129(4):431-7 [DOI] 10.1016/j.amjmed.2015.11.012. [PMID] 26642907.
2015
A randomized controlled trial of co-payment elimination: the CHORD trial.
The American journal of managed care. 21(8):e455-64 [PMID] 26625505.
2015
A randomized controlled trial of negative co-payments: the CHORD trial.
The American journal of managed care. 21(8):e465-73 [PMID] 26625506.
2015
Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment.
Thrombosis research. 136(1):180-1 [DOI] 10.1016/j.thromres.2015.05.006. [PMID] 26004747.
2015
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Stroke. 46(3):722-31 [DOI] 10.1161/STROKEAHA.114.006866. [PMID] 25657176.
2015
Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.
JAMA dermatology. 151(2):161-9 [DOI] 10.1001/jamadermatol.2014.2094. [PMID] 25322196.
2015
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis: comment.
Journal of thrombosis and haemostasis : JTH. 13(6):1162-4 [DOI] 10.1111/jth.12903. [PMID] 25780950.
2015
Factors affecting time to maintenance dose in patients initiating warfarin.
Pharmacoepidemiology and drug safety. 24(3):228-36 [DOI] 10.1002/pds.3735. [PMID] 25504915.
2015
Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis.
Thrombosis and haemostasis. 114(4):768-77 [DOI] 10.1160/TH15-01-0071. [PMID] 26158747.
2015
The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
American journal of cardiovascular drugs : drugs, devices, and other interventions. 15(4):267-74 [DOI] 10.1007/s40256-015-0126-3. [PMID] 26037731.
2015
Warfarin pharmacogenomics: current best evidence.
Journal of thrombosis and haemostasis : JTH. 13 Suppl 1:S266-71 [DOI] 10.1111/jth.12978. [PMID] 26149035.
2014
Genotype-guided dosing of vitamin K antagonists.
The New England journal of medicine. 370(18):1763-4 [DOI] 10.1056/NEJMc1402521. [PMID] 24785213.
2014
Prevalence and prognostic importance of changes in renal function after mechanical circulatory support.
Circulation. Heart failure. 7(1):68-75 [DOI] 10.1161/CIRCHEARTFAILURE.113.000507. [PMID] 24214901.
2013
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
The New England journal of medicine. 369(24):2283-93 [DOI] 10.1056/NEJMoa1310669. [PMID] 24251361.
2013
Amphetamines, atomoxetine and the risk of serious cardiovascular events in adults.
PloS one. 8(1) [DOI] 10.1371/journal.pone.0052991. [PMID] 23382829.
2013
Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.
Journal of clinical & experimental cardiology. Suppl 10(6):1-9 [PMID] 24027655.
2013
Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure.
Circulation. Heart failure. 6(2):233-9 [DOI] 10.1161/CIRCHEARTFAILURE.112.968230. [PMID] 23325460.
2013
Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study.
Thrombosis and haemostasis. 110(1):195-6 [DOI] 10.1160/TH13-02-0111. [PMID] 23572189.
2013
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.
JAMA dermatology. 149(10):1173-9 [DOI] 10.1001/jamadermatol.2013.5015. [PMID] 23925466.
2013
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.
American heart journal. 166(3):435-41 [DOI] 10.1016/j.ahj.2013.04.009. [PMID] 24016491.
2012
Factors associated with the initiation of proton pump inhibitors in corticosteroid users.
Pharmacoepidemiology and drug safety. 21(4):366-74 [DOI] 10.1002/pds.2350. [PMID] 22278844.
2012
Heart attack risk perception biases among hypertension patients: the role of educational level and worry.
Psychology & health. 27(6):737-51 [DOI] 10.1080/08870446.2011.626856. [PMID] 22148955.
2012
Methylphenidate and risk of serious cardiovascular events in adults.
The American journal of psychiatry. 169(2):178-85 [DOI] 10.1176/appi.ajp.2011.11010125. [PMID] 22318795.
2012
Novel incentive-based approaches to adherence.
Clinical trials (London, England). 9(6):689-95 [DOI] 10.1177/1740774512453520. [PMID] 22848071.
2012
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.
Thrombosis and haemostasis. 107(2):232-40 [DOI] 10.1160/TH11-06-0388. [PMID] 22186998.
2012
Randomized trial of lottery-based incentives to improve warfarin adherence.
American heart journal. 164(2):268-74 [DOI] 10.1016/j.ahj.2012.05.005. [PMID] 22877814.
2012
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.
Journal of viral hepatitis. 19(4):271-7 [DOI] 10.1111/j.1365-2893.2011.01545.x. [PMID] 22404725.
2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Pharmacoepidemiology and drug safety. 21(11):1202-15 [DOI] 10.1002/pds.3318. [PMID] 22763953.
2012
The Master of Science in clinical epidemiology degree program of the Perelman School of Medicine at the University of Pennsylvania: a model for clinical research training.
Academic medicine : journal of the Association of American Medical Colleges. 87(1):74-80 [DOI] 10.1097/ACM.0b013e31823ab5c2. [PMID] 22104053.
2011
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia.
Pharmacoepidemiology and drug safety. 20(9):903-13 [DOI] 10.1002/pds.2181. [PMID] 21796718.
2011
Cardiovascular events and death in children exposed and unexposed to ADHD agents.
Pediatrics. 127(6):1102-10 [DOI] 10.1542/peds.2010-3371. [PMID] 21576311.
2011
Cardiovascular pharmacogenomics.
Circulation research. 109(7):807-20 [DOI] 10.1161/CIRCRESAHA.110.230995. [PMID] 21921273.
2011
Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure.
Journal of cardiac failure. 17(12):993-1000 [DOI] 10.1016/j.cardfail.2011.08.009. [PMID] 22123361.
2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.
Clinical pharmacology and therapeutics. 90(4):625-9 [DOI] 10.1038/clpt.2011.185. [PMID] 21900891.
2011
Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women.
Journal of cardiovascular pharmacology. 57(2):194-200 [DOI] 10.1097/FJC.0b013e31820350d3. [PMID] 21052013.
2011
Genetic warfarin dosing: tables versus algorithms.
Journal of the American College of Cardiology. 57(5):612-8 [DOI] 10.1016/j.jacc.2010.08.643. [PMID] 21272753.
2011
Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes.
European journal of heart failure. 13(8):877-84 [DOI] 10.1093/eurjhf/hfr070. [PMID] 21693504.
2011
Impact of worsening renal function during the treatment of decompensated heart failure on changes in renal function during subsequent hospitalization.
American heart journal. 161(5):944-9 [DOI] 10.1016/j.ahj.2011.02.005. [PMID] 21570527.
2011
Influence of renal dysfunction phenotype on mortality in the setting of cardiac dysfunction: analysis of three randomized controlled trials.
European journal of heart failure. 13(11):1224-30 [DOI] 10.1093/eurjhf/hfr123. [PMID] 21926073.
2011
Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure.
Journal of the American College of Cardiology. 58(4):375-82 [DOI] 10.1016/j.jacc.2011.01.052. [PMID] 21757114.
2011
Medication adherence: a call for action.
American heart journal. 162(3):412-24 [DOI] 10.1016/j.ahj.2011.06.007. [PMID] 21884856.
2011
Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.
Circulation. Heart failure. 4(6):685-91 [DOI] 10.1161/CIRCHEARTFAILURE.111.963256. [PMID] 21903907.
2011
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
Kidney international. 79(2):250-7 [DOI] 10.1038/ki.2010.383. [PMID] 20927040.
2011
The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.
British journal of clinical pharmacology. 72(3):514-7 [DOI] 10.1111/j.1365-2125.2011.04008.x. [PMID] 21557758.
2011
Validity of The Health Improvement Network (THIN) for the study of psoriasis.
The British journal of dermatology. 164(3):602-9 [DOI] 10.1111/j.1365-2133.2010.10134.x. [PMID] 21073449.
2010
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
Chest. 137(4):883-9 [DOI] 10.1378/chest.09-0039. [PMID] 19903973.
2010
Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
Pharmacoepidemiology and drug safety. 19(9):934-41 [DOI] 10.1002/pds.1992. [PMID] 20623519.
2010
Construct validity of the definition of primary graft dysfunction after lung transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 29(11):1231-9 [DOI] 10.1016/j.healun.2010.05.013. [PMID] 20655249.
2010
Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis.
British journal of clinical pharmacology. 70(1):118-25 [DOI] 10.1111/j.1365-2125.2010.03670.x. [PMID] 20642554.
2010
Factors associated with the use of corticosteroids in the initial management of idiopathic pulmonary fibrosis.
Pharmacoepidemiology and drug safety. 19(7):756-62 [DOI] 10.1002/pds.1959. [PMID] 20582912.
2010
Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial).
The American journal of cardiology. 105(7):943-7 [DOI] 10.1016/j.amjcard.2009.11.019. [PMID] 20346310.
2010
Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults.
Pharmacoepidemiology and drug safety. 19(7):731-6 [DOI] 10.1002/pds.1953. [PMID] 20583203.
2010
Integration of genetic, clinical, and INR data to refine warfarin dosing.
Clinical pharmacology and therapeutics. 87(5):572-8 [DOI] 10.1038/clpt.2010.13. [PMID] 20375999.
2010
New genetic variant that might improve warfarin dose prediction in African Americans.
British journal of clinical pharmacology. 70(3):393-9 [DOI] 10.1111/j.1365-2125.2010.03709.x. [PMID] 20716240.
2010
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.
International journal of behavioral medicine. 17(1):33-42 [DOI] 10.1007/s12529-009-9052-6. [PMID] 19579066.
2010
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.
Circulation. 122(3):265-72 [DOI] 10.1161/CIRCULATIONAHA.109.933275. [PMID] 20606118.
2010
Predictors of complications following sheath removal with percutaneous coronary intervention.
The Journal of cardiovascular nursing. 25(3):E1-8 [DOI] 10.1097/JCN.0b013e3181c83f4b. [PMID] 20357666.
2010
Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
Clinical trials (London, England). 7(5):597-604 [DOI] 10.1177/1740774510381285. [PMID] 20693186.
2010
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
Trials. 11 [DOI] 10.1186/1745-6215-11-108. [PMID] 21083927.
2010
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data.
Pharmacoepidemiology and drug safety. 19(6):555-62 [DOI] 10.1002/pds.1869. [PMID] 19844945.
2010
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Blood. 115(18):3827-34 [DOI] 10.1182/blood-2009-12-255992. [PMID] 20203262.
2009
Estimation of the warfarin dose with clinical and pharmacogenetic data.
The New England journal of medicine. 360(8):753-64 [DOI] 10.1056/NEJMoa0809329. [PMID] 19228618.
2009
Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans.
Circulation. 119(3):390-7 [DOI] 10.1161/CIRCULATIONAHA.108.783944. [PMID] 19139387.
2009
Increased risk of digoxin toxicity following hospitalization.
Pharmacoepidemiology and drug safety. 18(1):28-35 [DOI] 10.1002/pds.1680. [PMID] 19040200.
2009
Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.
Circulation. 120(4):310-7 [DOI] 10.1161/CIRCULATIONAHA.109.856310. [PMID] 19597049.
2009
Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
American heart journal. 157(5):867-74 [DOI] 10.1016/j.ahj.2009.02.019. [PMID] 19376313.
2008
A test of financial incentives to improve warfarin adherence.
BMC health services research. 8 [DOI] 10.1186/1472-6963-8-272. [PMID] 19102784.
2008
Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans.
The pharmacogenomics journal. 8(1):53-60 [PMID] 17325732.
2008
Cisapride and ventricular arrhythmia.
British journal of clinical pharmacology. 66(3):375-85 [DOI] 10.1111/j.1365-2125.2008.03249.x. [PMID] 18662288.
2008
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC’s General Practice Research Database.
Pharmacoepidemiology and drug safety. 17(12):1131-6 [DOI] 10.1002/pds.1632. [PMID] 18613261.
2008
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events.
Journal of clinical epidemiology. 61(6):561-71 [DOI] 10.1016/j.jclinepi.2007.08.003. [PMID] 18471660.
2008
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.
Clinical pharmacology and therapeutics. 84(3):332-9 [DOI] 10.1038/clpt.2008.101. [PMID] 18596683.
2008
Epidemiologic features of the presentation of critical congenital heart disease: implications for screening.
Pediatrics. 121(4):751-7 [DOI] 10.1542/peds.2007-0421. [PMID] 18381540.
2008
Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.
Pharmacogenomics. 9(9):1331-46 [DOI] 10.2217/14622416.9.9.1331. [PMID] 18781859.
2008
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population.
Pharmacoepidemiology and drug safety. 17(1):43-51 [PMID] 17960855.
2008
Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity.
Pharmacoepidemiology and drug safety. 17(4):328-35 [DOI] 10.1002/pds.1546. [PMID] 18188866.
2008
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events.
Journal of general internal medicine. 23(10):1589-94 [DOI] 10.1007/s11606-008-0708-8. [PMID] 18618191.
2008
Risk factors for nonadherence to warfarin: results from the IN-RANGE study.
Pharmacoepidemiology and drug safety. 17(9):853-60 [DOI] 10.1002/pds.1556. [PMID] 18271059.
2008
Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study.
Heart rhythm. 5(2):174-81 [DOI] 10.1016/j.hrthm.2007.09.024. [PMID] 18242535.
2008
Warfarin therapy: in need of improvement after all these years.
Expert opinion on pharmacotherapy. 9(5):677-86 [DOI] 10.1517/14656566.9.5.677. [PMID] 18345947.
2008
Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding.
Clinical pharmacology and therapeutics. 84(5):581-8 [DOI] 10.1038/clpt.2008.150. [PMID] 18685566.
2007
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures).
Circulation. 116(1):98-124 [PMID] 17592076.
2007
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures).
Journal of the American College of Cardiology. 50(1):82-108 [PMID] 17601554.
2007
Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.
Journal of general internal medicine. 22(9):1254-9 [PMID] 17587092.
2007
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.
Archives of internal medicine. 167(3):229-35 [PMID] 17296877.
2007
Value of electrocardiographic and ankle-brachial index abnormalities for prediction of coronary atherosclerosis in asymptomatic subjects with type 2 diabetes mellitus.
The American journal of cardiology. 99(7):951-5 [PMID] 17398190.
2007
Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.
Pharmacogenomics. 8(3):217-25 [PMID] 17324110.
2007
Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.
Clinical pharmacology and therapeutics. 81(5):742-7 [PMID] 17329985.
2006
A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension.
The European respiratory journal. 27(3):578-84 [PMID] 16507859.
2006
Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results.
The journal of sexual medicine. 3(2):303-8 [PMID] 16490024.
2006
Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study.
Journal of cardiovascular electrophysiology. 17(10):1074-9 [PMID] 16879626.
2006
Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial.
Pharmacotherapy. 26(9):1342-7 [PMID] 16945057.
2006
Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus.
The American journal of cardiology. 97(5):651-4 [PMID] 16490431.
2006
Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure.
Pharmacoepidemiology and drug safety. 15(1):39-45 [PMID] 16136614.
2006
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis.
Journal of the American College of Cardiology. 47(3):529-37 [PMID] 16458131.
2005
Hemodynamics and survival of patients with portopulmonary hypertension.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 11(9):1107-11 [PMID] 16123953.
2005
Impact of primary graft failure on outcomes following lung transplantation.
Chest. 127(1):161-5 [PMID] 15653978.
2005
Medication safety in older adults: home-based practice patterns.
Journal of the American Geriatrics Society. 53(6):976-82 [PMID] 15935020.
2005
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.
Annals of internal medicine. 142(3):157-64 [PMID] 15684203.
2005
Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Pharmacoepidemiology and drug safety. 14(8):513-22 [PMID] 15959879.
2005
Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Gastroenterology. 129(6):1865-74 [PMID] 16344055.
2005
Role of computerized physician order entry systems in facilitating medication errors.
JAMA. 293(10):1197-203 [PMID] 15755942.
2005
The effect of cardiac troponin testing on clinical care in a veterans population: a randomized controlled trial.
Journal of general internal medicine. 20(7):584-92 [PMID] 16050851.
2005
The effect of primary graft dysfunction on survival after lung transplantation.
American journal of respiratory and critical care medicine. 171(11):1312-6 [PMID] 15764726.
2004
Association between pulmonary fibrosis and coronary artery disease.
Archives of internal medicine. 164(5):551-6 [PMID] 15006833.
2004
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
The American journal of cardiology. 94(9):1171-3 [PMID] 15518614.
2004
Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol.
British journal of clinical pharmacology. 58(1):81-7 [PMID] 15206997.
2004
Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
The American journal of cardiology. 94(4):479-81 [PMID] 15325933.
2004
Is improved survival a class effect of angiotensin-converting enzyme inhibitors?
Annals of internal medicine. 141(2):157-8 [PMID] 15262673.
2004
Malignant peripheral nerve sheath tumor arising from an adrenal ganglioneuroma in a 6-year-old boy.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 7(3):277-84 [PMID] 15022069.
2004
Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes.
The Journal of clinical endocrinology and metabolism. 89(8):3872-8 [PMID] 15292320.
2004
The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
Journal of the American College of Cardiology. 43(6):985-90 [PMID] 15028354.
2003
Adverse events after protamine administration following cardiopulmonary bypass in infants and children.
Anesthesia and analgesia. 97(2):383-389 [DOI] 10.1213/01.ANE.0000072545.13681.FA. [PMID] 12873922.
2003
Bleeding risk of platelet glycoprotein IIb/IIIa receptor antagonists in broad-based practice (results from the Society for Cardiac Angiography and Interventions Registry).
The American journal of cardiology. 91(7):803-6 [PMID] 12667564.
2003
Clinical risk factors for primary graft failure following lung transplantation.
Chest. 124(4):1232-41 [PMID] 14555551.
2003
Computer games may be good for your health: shifting healthcare behavior via interactive drama videogames.
AMIA … Annual Symposium proceedings. AMIA Symposium. 2003 [PMID] 14728578.
2003
Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.
Circulation. 108(1):32-6 [PMID] 12821544.
2003
Enhancement of medication recall using medication pictures and lists in telephone interviews.
Pharmacoepidemiology and drug safety. 12(1):1-8 [PMID] 12622055.
2003
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.
Chest. 123(2):344-50 [PMID] 12576350.
2003
Limitations of current risk-adjustment models in the era of coronary stenting.
American heart journal. 145(4):683-92 [PMID] 12679766.
2003
One-year clinical outcomes of protected and unprotected left main coronary artery stenting.
European heart journal. 24(17):1554-9 [PMID] 12927190.
2003
The relative safety of ephedra compared with other herbal products.
Annals of internal medicine. 139(3) [PMID] 12899599.
2002
Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial.
Stroke. 33(1):130-4 [PMID] 11779901.
2002
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.
BMJ (Clinical research ed.). 325(7372) [PMID] 12424166.
2002
Cigarette yield and the risk of myocardial infarction in smokers.
Archives of internal medicine. 162(3):300-6 [PMID] 11822922.
2002
Computer games may be good for your health.
Journal of healthcare information management : JHIM. 16(2):80-5 [PMID] 11941928.
2002
Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass.
Anesthesia and analgesia. 94(6):1402-8, table of contents [PMID] 12031996.
2002
Parenteral ketorolac and risk of myocardial infarction.
Pharmacoepidemiology and drug safety. 11(2):113-9 [PMID] 11998535.
2002
Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography.
The American journal of cardiology. 90(4):395-400 [PMID] 12161229.
2002
Relationship between coronary angioplasty laboratory volume and outcomes after hospital discharge.
American heart journal. 143(5):833-40 [PMID] 12040345.
2002
Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial.
Journal of the American College of Cardiology. 39(10):1601-7 [PMID] 12020486.
2002
Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial.
The American journal of cardiology. 90(9):922-6 [PMID] 12398955.
2001
Adjustments for center in multicenter studies: an overview.
Annals of internal medicine. 135(2):112-23 [PMID] 11453711.
2001
Epidemiologic review of the calcium channel blocker drugs. An up-to-date perspective on the proposed hazards.
Archives of internal medicine. 161(9):1145-58 [PMID] 11343438.
2001
Incidence and prognostic value of low plasma ionized calcium concentration in cats with acute pancreatitis: 46 cases (1996-1998).
Journal of the American Veterinary Medical Association. 219(8):1105-9 [PMID] 11700709.
2001
Modeling emotion and behavior in animated personas to facilitate human behavior change: the case of the HEART-SENSE game.
Health care management science. 4(3):213-28 [PMID] 11519847.
2001
Perioperative beta-blocker withdrawal and mortality in vascular surgical patients.
American heart journal. 141(1):148-53 [PMID] 11136500.
2001
Risk of acute first myocardial infarction and use of nicotine patches in a general population.
Journal of the American College of Cardiology. 37(5):1297-302 [PMID] 11300438.
2001
Secondary hypoparathyroidism attributed to hypomagnesemia in a dog with protein-losing enteropathy.
Journal of the American Veterinary Medical Association. 219(12):1732-4, 1708 [PMID] 11767924.
2001
Selective serotonin reuptake inhibitors and myocardial infarction.
Circulation. 104(16):1894-8 [PMID] 11602490.
2001
The effects of contemporary use of coronary stents on in-hospital mortality. Registry Committee of the Society for Cardiac Angiography and Interventions.
Journal of the American College of Cardiology. 37(2):499-504 [PMID] 11216969.
2000
A simplified lesion classification for predicting success and complications of coronary angioplasty. Registry Committee of the Society for Cardiac Angiography and Intervention.
The American journal of cardiology. 85(10):1179-84 [PMID] 10801997.
2000
Accuracy of initial stroke subtype diagnosis. a decision analysis.
Cerebrovascular diseases (Basel, Switzerland). 10(1):18-24 [PMID] 10629342.
2000
Effects of coronary stents on cardiovascular outcomes in broad-based clinical practice.
Archives of internal medicine. 160(17):2593-9 [PMID] 10999972.
2000
Effects of insoluble and soluble dietary fiber on glycemic control in dogs with naturally occurring insulin-dependent diabetes mellitus.
Journal of the American Veterinary Medical Association. 216(7):1076-81 [PMID] 10754666.
2000
Efficacy and safety of catheter ablation in octogenarians.
Journal of the American College of Cardiology. 35(2):458-62 [PMID] 10676694.
2000
Hypomagnesemia and hypocalcemia associated with protein-losing enteropathy in Yorkshire terriers: five cases (1992-1998).
Journal of the American Veterinary Medical Association. 217(5):703-6 [PMID] 10976303.
2000
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel.
The American journal of cardiology. 86(2A):62F-68F [PMID] 10899282.
2000
Sex and myocardial infarction: an epidemiologic perspective.
The American journal of cardiology. 86(2A):10F-13F [PMID] 10899270.
2000
The calcium-channel blocker controversy: historical perspective and important lessons for future pharmacotherapies. An international society of pharmacoepidemiology ‘hot topic’.
Pharmacoepidemiology and drug safety. 9(1):25-35 [DOI] 10.1002/(SICI)1099-1557(200001/02)9:1<25::AID-PDS469>3.0.CO;2-E. [PMID] 19025799.
1999
An empirical comparison of several clustered data approaches under confounding due to cluster effects in the analysis of complications of coronary angioplasty.
Biometrics. 55(2):470-6 [PMID] 11318202.
1999
Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota.
The American journal of cardiology. 84(3):304-8 [PMID] 10496440.
1999
Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure.
The American journal of cardiology. 83(11):1544-7 [PMID] 10363868.
1998
Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.
Journal of clinical epidemiology. 51(1):1-10 [PMID] 9467629.
1998
Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.
Journal of the American College of Cardiology. 32(7):1916-22 [PMID] 9857872.
1997
Lack of hepatotoxic effects of parenteral ketorolac in the hospital setting.
Archives of internal medicine. 157(21):2510-4 [PMID] 9385304.
1997
Parenteral ketorolac: the risk for acute renal failure.
Annals of internal medicine. 126(3):193-9 [PMID] 9027269.
1997
Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography: results from the Registry of the Society for Cardiac Angiography and Interventions.
Journal of the American College of Cardiology. 30(1):193-200 [PMID] 9207642.
1996
Calcium-channel blockers in ischemic heart disease.
Current opinion in cardiology. 11(4):434-9 [PMID] 8879955.
1996
Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.
JAMA. 275(5):376-82 [PMID] 8569017.
1995
Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions.
Journal of the American College of Cardiology. 26(4):931-8 [PMID] 7560620.
1995
The relationship between coronary angioplasty procedure volume and major complications.
JAMA. 274(14):1137-42 [PMID] 7563484.
1992
Inaccuracies in certification of nonmelanoma skin cancer deaths.
American journal of public health. 82(2):278-81 [PMID] 1739165.

Grants

Sep 2024 ACTIVE
A novel framework for estimating personalized genomic variants of hypertension for precision medicine
Role: Other
Funding: NATL INST OF HLTH NHLBI
Jul 2023 ACTIVE
Together: Transforming and Translating Discovery to Improve Health
Role: Faculty
Funding: NATL INST OF HLTH NCATS
May 2023 ACTIVE
Training Program for Applied Research and Development in Genomic Medicine
Role: Principal Investigator
Funding: NATL INST OF HLTH NHGRI
Jul 2022 – Jun 2024
Social Determinants Underlying Disparities in Heart Failure Treatment and Outcomes
Role: Co-Investigator
Funding: PHARMA RES AND MANUFACTURERS OF AMERICA
Jul 2022 – Jun 2024
Together: Transforming and Translating Discovery to Improve Health
Role: Faculty
Funding: NATL INST OF HLTH NCATS
Jul 2022 – Jun 2023
Risk of adverse cardiovascular events in breast cancer patients receiving systemic adjuvant therapy: impact of comorbidity burden
Role: Co-Investigator
Funding: FL BREAST CANCER FOU
Nov 2021 – Nov 2022
Implementation Strategies for Monitoring Adherence in Real Time (iSMART)
Role: Principal Investigator
Funding: UNIV OF PENNSYLVANIA via PFIZER INC
Sep 2021 ACTIVE
Alcohol-Associated Syndemic and Microbiome Evaluation and Targeted Treatment in Persons Living with HIV
Role: Other
Funding: NATL INST OF HLTH NIAAA
Jul 2021 – May 2024
Together: Transforming and Translating Discovery to Improve Health
Role: Other
Funding: NATL INST OF HLTH NCATS
Feb 2021 – Jan 2024
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
Role: Principal Investigator
Funding: UNIV OF PENNSYLVANIA via NATL INST OF HLTH NHLBI
Jan 2021 – May 2023
Digital Phenotyping and Cardiovascular Health
Role: Principal Investigator
Funding: UNIV OF PENNSYLVANIA via NATL INST OF HLTH NHLBI
Jan 2021 – May 2022
Enhancing the Utility of the Trend-in-Trend Research Design
Role: Principal Investigator
Funding: UNIV OF PENNSYLVANIA via NATL INST OF HLTH NIA
Jan 2021 – Aug 2021
A general framework to account for outcome reporting bias with systematic reviews
Role: Principal Investigator
Funding: UNIV OF PENNSYLVANIA via NATL INST OF HLTH NLM
Dec 2020 – Jul 2024
Dynamic Prediction Modeling to Improve Clinical Predictions
Role: Principal Investigator
Funding: NATL INST OF HLTH NHLBI
Aug 2020 – Sep 2021
The External Exposome and COVID-19 Severity
Role: Project Manager
Funding: NATL INST OF HLTH NIEHS
Jan 2018 – Apr 2023
Training Program for Applied Research and Development in Genomic Medicine
Role: Principal Investigator
Funding: NATL INST OF HLTH NHGRI

Education

MSCE
1995 · University of Pennsylvania
MD
1988 · New York University School of Medicine
AB
1984 · Princeton University

Contact Details

Phones:
Business:
(352) 273-5460
Emails:
Business:
skimmel@ufl.edu
Addresses:
Business Mailing:
PO Box 100231
GAINESVILLE FL 32610